ATE231496T1 - Saccharinderivate als proteolytische enzyminhibitoren - Google Patents

Saccharinderivate als proteolytische enzyminhibitoren

Info

Publication number: ATE231496T1
Authority: AT; Austria
Prior art keywords: proteolytic; enzymin; hibitors; saccharine derivatives; saccharine
Prior art date: 1993-05-25

Application number

AT94201437T

Other languages

English (en)

Inventor

Dennis John Hlasta

James H Ackerman

Albert J Mura

Ranjit Ch Desai

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-25

Filing date

1994-05-21

Publication date

2003-02-15

1994-05-21 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2003-02-15 Application granted granted Critical

2003-02-15 Publication of ATE231496T1 publication Critical patent/ATE231496T1/de

Links

230000002797 proteolythic effect Effects 0.000 title 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical class C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 title 1
238000000034 method Methods 0.000 abstract 2
102000035195 Peptidases Human genes 0.000 abstract 1
108091005804 Peptidases Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000002255 enzymatic effect Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrrole Compounds (AREA)
Cosmetics (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT94201437T 1993-05-25 1994-05-21 Saccharinderivate als proteolytische enzyminhibitoren ATE231496T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/066,805 US5378720A (en)	1991-12-19	1993-05-25	Saccharin derivative proteolytic enzyme inhibitors

Publications (1)

Publication Number	Publication Date
ATE231496T1 true ATE231496T1 (de)	2003-02-15

Family

ID=22071832

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94201437T ATE231496T1 (de)	1993-05-25	1994-05-21	Saccharinderivate als proteolytische enzyminhibitoren

Country Status (21)

Country	Link
US (2)	US5378720A (de)
EP (1)	EP0626378B1 (de)
JP (1)	JPH0770094A (de)
KR (1)	KR100334345B1 (de)
AT (1)	ATE231496T1 (de)
AU (1)	AU685785B2 (de)
CA (1)	CA2122886A1 (de)
CZ (1)	CZ289573B6 (de)
DE (1)	DE69432035D1 (de)
FI (1)	FI942423A7 (de)
HU (1)	HUT70760A (de)
IL (1)	IL109780A (de)
MY (1)	MY129998A (de)
NO (1)	NO302474B1 (de)
NZ (1)	NZ260585A (de)
PH (1)	PH31435A (de)
RU (1)	RU2126798C1 (de)
SG (1)	SG55137A1 (de)
SK (1)	SK281020B6 (de)
TW (1)	TW420679B (de)
UA (1)	UA44682C2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6509006B1 (en)	1992-07-08	2003-01-21	Inhale Therapeutic Systems, Inc.	Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en)	1992-07-08	2003-06-24	Inhale Therapeutic Systems, Inc.	Spray drying of macromolecules to produce inhaleable dry powders
WO1995013075A1 (en) *	1993-11-12	1995-05-18	Cell Therapeutics, Inc.	Method for preventing tissue injury from hypoxia
US6290991B1 (en)	1994-12-02	2001-09-18	Quandrant Holdings Cambridge Limited	Solid dose delivery vehicle and methods of making same
US5541168A (en) *	1994-12-02	1996-07-30	Sterling Winthrop Inc.	Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5556909A (en) *	1994-12-02	1996-09-17	Sanofi Winthrop Inc.	Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
US5494925A (en) *	1994-12-02	1996-02-27	Sterling Winthrop Inc.	2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5512576A (en) *	1994-12-02	1996-04-30	Sterling Winthrop Inc.	2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5780014A (en) *	1995-04-14	1998-07-14	Inhale Therapeutic Systems	Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5750550A (en) *	1995-09-15	1998-05-12	Sanofi	2-(pyrazol-5-yl-oxymethyl)-1,2-benzisothiazol-3 (2H)-One 1, 1-dioxides and compositions and method of use thereof
HUP9904624A2 (hu) *	1999-12-17	2002-01-28	Sanofi-Synthelabo	Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik
US7482366B2 (en)	2001-12-21	2009-01-27	X-Ceptor Therapeutics, Inc.	Modulators of LXR
US7998986B2 (en) *	2001-12-21	2011-08-16	Exelixis Patent Company Llc	Modulators of LXR
AP1822A (en) *	2002-02-14	2008-01-30	Pharmacia Corp	Substituted pyridinones as modulators of P38 MAP kinase.
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) *	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
EA017648B1 (ru) *	2007-09-14	2013-02-28	Орто-Макнейл-Янссен Фармасьютикалз, Инк.	1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
BRPI0816970A2 (pt) *	2007-09-14	2015-03-24	Ortho Mcneil Janssen Pharm	1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
TW200922566A (en)	2007-09-14	2009-06-01	Ortho Mcneil Janssen Pharm	1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
CA2704436C (en) *	2007-11-14	2016-01-05	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8324405B2 (en)	2008-02-05	2012-12-04	Fibrogen, Inc.	Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors
JP5547194B2 (ja)	2008-09-02	2014-07-09	ジャンセンファーマシューティカルズ，インコーポレイテッド．	代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
WO2010043396A1 (en)	2008-10-16	2010-04-22	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010056767A1 (en)	2008-11-14	2010-05-20	Fibrogen, Inc.	Thiochromene derivatives as hip hydroxylase inhibitors
JP5690277B2 (ja)	2008-11-28	2015-03-25	ジャンセンファーマシューティカルズ，インコーポレイテッド．	代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
CN102439015B (zh)	2009-05-12	2015-05-13	杨森制药有限公司	1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
HRP20131122T1 (hr)	2009-05-12	2013-12-20	Janssen Pharmaceuticals, Inc.	Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
EP2661435B1 (de)	2010-11-08	2015-08-19	Janssen Pharmaceuticals, Inc.	1,2,4-triazol[4,3-a]pyridinderivate und ihre verwendung als positive allosterische mglur2-rezeptormodulatoren
ES2536433T3 (es)	2010-11-08	2015-05-25	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852664B2 (ja)	2010-11-08	2016-02-03	ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド	１，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PL3096790T3 (pl)	2014-01-21	2020-01-31	Janssen Pharmaceutica, N.V.	Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
ME03518B (de)	2014-01-21	2020-04-20	Janssen Pharmaceutica Nv	Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung
JP2024506858A (ja)	2021-02-02	2024-02-15	リミナル・バイオサイエンシーズ・リミテッド	Ｇｐｒ８４アンタゴニストおよびその使用
KR20230153387A (ko)	2021-02-02	2023-11-06	리미널 바이오사이언시스 리미티드	Gpr84 길항제 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2855401A (en) *	1954-04-30	1958-10-07	May & Baker Ltd	Certain n-(aminophenoxy pentyl) sulfonamide or saccharine compounds and higher homologues
US3220940A (en) *	1962-02-07	1965-11-30	Udylite Res Corp	Electrodeposition of nickel
US4195023A (en) *	1975-08-20	1980-03-25	Merck & Co., Inc.	2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) *	1978-03-24	1981-06-30	Merck & Co., Inc.	2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
DE3617976A1 (de) *	1986-05-28	1988-01-14	Alter Sa	1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
US5128339A (en) *	1990-11-01	1992-07-07	Sterling Winthrop Inc.	Proteolytic enzyme inhibition method
US5236917A (en) *	1989-05-04	1993-08-17	Sterling Winthrop Inc.	Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
KR0183397B1 (ko) *	1989-05-04	1999-05-01	존 엠. 스피나토	단백질 분해 효소 저해제로서 유용한 사카린 유도체들 및 그의 제조방법
AU642537B2 (en) *	1990-11-01	1993-10-21	Sanofi	2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU656027B2 (en) *	1991-11-15	1995-01-19	Sanofi	Saccharin derivative proteolytic enzime inhibitors
AU668694B2 (en) *	1991-12-19	1996-05-16	Sanofi-Synthelabo	Saccharin derivative proteolytic enzyme inhibitors

1993
- 1993-05-25 US US08/066,805 patent/US5378720A/en not_active Expired - Fee Related
1994
- 1994-03-30 TW TW083102772A patent/TW420679B/zh not_active IP Right Cessation
- 1994-04-25 IL IL10978094A patent/IL109780A/en not_active IP Right Cessation
- 1994-05-04 CA CA002122886A patent/CA2122886A1/en not_active Abandoned
- 1994-05-21 AT AT94201437T patent/ATE231496T1/de not_active IP Right Cessation
- 1994-05-21 SG SG1996007480A patent/SG55137A1/en unknown
- 1994-05-21 DE DE69432035T patent/DE69432035D1/de not_active Expired - Lifetime
- 1994-05-21 EP EP94201437A patent/EP0626378B1/de not_active Expired - Lifetime
- 1994-05-24 JP JP6109826A patent/JPH0770094A/ja active Pending
- 1994-05-24 RU RU94017851/04A patent/RU2126798C1/ru not_active IP Right Cessation
- 1994-05-24 UA UA94005229A patent/UA44682C2/uk unknown
- 1994-05-24 AU AU63280/94A patent/AU685785B2/en not_active Ceased
- 1994-05-24 PH PH48322A patent/PH31435A/en unknown
- 1994-05-24 MY MYPI94001318A patent/MY129998A/en unknown
- 1994-05-24 KR KR1019940011321A patent/KR100334345B1/ko not_active Expired - Fee Related
- 1994-05-24 CZ CZ19941268A patent/CZ289573B6/cs not_active IP Right Cessation
- 1994-05-24 NZ NZ260585A patent/NZ260585A/en unknown
- 1994-05-25 FI FI942423A patent/FI942423A7/fi unknown
- 1994-05-25 SK SK615-94A patent/SK281020B6/sk unknown
- 1994-05-25 NO NO941937A patent/NO302474B1/no not_active IP Right Cessation
- 1994-05-25 HU HU9401571A patent/HUT70760A/hu unknown
- 1994-06-22 US US08/263,643 patent/US5466701A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SG55137A1 (en)	1998-12-21
AU685785B2 (en)	1998-01-29
EP0626378B1 (de)	2003-01-22
NO941937D0 (no)	1994-05-25
IL109780A (en)	1998-08-15
CZ289573B6 (cs)	2002-02-13
DE69432035D1 (de)	2003-02-27
KR100334345B1 (ko)	2002-08-27
SK61594A3 (en)	1995-02-08
JPH0770094A (ja)	1995-03-14
NZ260585A (en)	1996-01-26
HUT70760A (en)	1995-10-30
NO941937L (no)	1994-11-28
FI942423A7 (fi)	1994-11-26
CA2122886A1 (en)	1994-11-26
US5378720A (en)	1995-01-03
NO302474B1 (no)	1998-03-09
CZ126894A3 (en)	1994-12-15
TW420679B (en)	2001-02-01
FI942423A0 (fi)	1994-05-25
UA44682C2 (uk)	2002-03-15
MY129998A (en)	2007-05-31
PH31435A (en)	1998-11-03
AU6328094A (en)	1994-12-01
IL109780A0 (en)	1994-08-26
SK281020B6 (sk)	2000-11-07
US5466701A (en)	1995-11-14
EP0626378A1 (de)	1994-11-30
RU2126798C1 (ru)	1999-02-27
HU9401571D0 (en)	1994-08-29

Legal Events

Date	Code	Title	Description
2003-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE233250T1 (de)	2003-03-15	Saccharinderivate als proteolytische enzyminhibitoren
DE69432035D1 (de)	2003-02-27	Saccharinderivate als proteolytische Enzyminhibitoren
BR1101081A (pt)	2000-03-28	Composto e composição farmacêutica
EP0471756A4 (en)	1992-04-08	Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
RU94017851A (ru)	1996-01-10	Ингибиторы протеолитических ферментов на основе производных сахарина, фармацевтическая композиция для лечения дегеративных заболеваний
AU667593B2 (en)	1996-03-28	Inhibitors of HIV protease useful for the treatment of AIDS
DE69413167D1 (de)	1998-10-15	Peptid-Phosphinyloxymethyl-Ketonen als Inhibitoren von Interleukin-1 beta-konvertierenden Enzymen
ATE265409T1 (de)	2004-05-15	Von aminosauren und hydroxysauren substituierte benzamidinderivate und deren verwendung als antikoagulantien
KR0148213B1 (en)	1998-08-17	Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
GR3022604T3 (en)	1997-05-31	Inhibitors of hiv protease useful for the treatment of aids.
EP0333000A3 (en)	1990-11-28	Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
ATE258229T1 (de)	2004-02-15	Substanz fa-70d, herstellungsverfahren und verwendungen
EP0332999A3 (en)	1990-11-28	Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
AU6029090A (en)	1991-02-14	Improvements in or relating to organic compounds
GEP20022764B (en)	2002-08-26	HIV Protease Inhibitors, Pharmaceutical Compositions and Methods for Inhibiting HIV Protease
WO1998009951A3 (en)	1998-07-09	Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors